Abiopharma

Director PROEHL GERALD T 🟢 acquired 37.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000698

Swanton Robert Charles 🟢 acquired 11.2K shares (1 derivative) of BICYCLE THERAPEUTICS PLC (BCYC) at $7.08 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Director HALE DAVID F 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000703

Director WIERENGA WENDELL 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000699

Bedoya-Toro Munera Maria E 🟢 acquired 9.0K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000704

Director Scott Kathleen D. 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000697

Director Mento Steven J 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000695

Van Hoose Kyri K. 🟢 acquired 18.0K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000701

Director FISHER MARY 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000700

Director Bradrick Brittany 🟢 acquired 2.5K shares (1 derivative) of Dermata Therapeutics, Inc. (DRMA) at $2.18 Transaction Date: Jan 02, 2026 | Filing ID: 000694

Director Zanganeh Mahkam 🟢 acquired 11.2K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000003

LO FRANCIS 🟡 adjusted position in 3.1K shares (1 derivative) of Adaptive Biotechnologies Corp (ADPT) at $16.08 Transaction Date: Jan 02, 2026 | Filing ID: 000001

Director DUGGAN ROBERT W 🟢 acquired 11.2K shares (1 derivative) of Summit Therapeutics Inc. (SMMT) at $17.52 Transaction Date: Jan 02, 2026 | Filing ID: 000003

Summit Plc - Statement of changes in beneficial ownership of securities

New Form SCHEDULE 13D/A - Anixa Biosciences Inc Filed: 2026-01-06 AccNo: 0001493152-26-000691 Size: 6 KB